After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in the form of a safety-related boxed warning. The label update ...

Learn more › You likely know Teva best for its extensive sandals, which it has been making since the mid-’80s. Now, the company has released its first truly winterized hiking boots ...

The FDA reported that six patients died after being injected with Teva’s Copaxone or Sandoz’s Glatopa. Pharmaceutical companies brace for the upcoming Trump administration. Teva ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

1 Day TEVA -0.50% DJIA -0.32% S&P 500 -0.29% Health Care/Life Sciences -0.52% ...

Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone. The ...

Raoom Trading 9M 2024 net profit up 8% to SAR 39.2M 9 M 2024 Raoom’s H1 2024 profit up 2% to SAR 28.3M; Q2 at SAR 4.4M 6 M 2024 Raoom’s 2023 profit rises to SAR 46.6M; Q4 at SAR 10.1M 12 M 2023 Raoom ...